Akari Therapeutics Other Long Term Liabilities (Quarterly) Insights

Akari Therapeutics Plc (AKTX)

0.2584 +0.02 (+6.34%) USD | NASDAQ | Feb 24, 16:00

0.2584 0.00 (0.00%) After-Hours: 20:00

View Other Long Term Liabilities (Quarterly) for AKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

DBV Technologies SA	Upgrade
Cellectis SA	Upgrade
Biodexa Pharmaceuticals Plc	Upgrade
NuCana Plc	--
Autolus Therapeutics Plc	Upgrade